Provided by Tiger Fintech (Singapore) Pte. Ltd.

Hims & Hers Health Inc.

25.99
-2.0000-7.15%
Post-market: 25.45-0.5400-2.08%19:59 EDT
Volume:27.69M
Turnover:712.35M
Market Cap:5.77B
PE:48.83
High:27.09
Open:26.30
Low:23.97
Close:27.99
Loading ...

Hims & Hers to Sell Branded Tirzepatide via Telehealth Platform

MT Newswires Live
·
02 Apr

Hims & Hers Health Says Adding Access to Generic Liraglutide and Branded Tirzepatide Through Our Platform - Website

THOMSON REUTERS
·
02 Apr

Hims & Hers to Sell Eli Lilly's Zepbound via Telehealth Platform, Bloomberg Reports

MT Newswires Live
·
02 Apr

1 Stock Under $50 on Our Watchlist and 2 to Turn Down

StockStory
·
31 Mar

3 Growth Companies With Insider Ownership Up To 28%

Simply Wall St.
·
29 Mar

March 2025's Top Growth Stocks With High Insider Confidence

Simply Wall St.
·
28 Mar

Hims & Hers Health (HIMS) Moves 5.7% Higher: Will This Strength Last?

Zacks
·
24 Mar

With A 29% Price Drop For Hims & Hers Health, Inc. (NYSE:HIMS) You'll Still Get What You Pay For

Simply Wall St.
·
24 Mar

Sale of Ozempic Knockoffs Are Supposed to End Soon. Telehealth Companies Aren't Happy. -- WSJ

Dow Jones
·
19 Mar

2 Healthcare Stocks with Solid Fundamentals and 1 to Brush Off

StockStory
·
18 Mar

Hims & Hers Health Inc : Bofa Global Research Raises Price Objective to $22 From $21

THOMSON REUTERS
·
18 Mar

Hims & Hers (HIMS) Investors Pulling Their Hair Out Over Pills Side-Effects

TIPRANKS
·
14 Mar

2 High-Flying Stocks with Exciting Potential and 1 to Turn Down

StockStory
·
13 Mar

These 20 stocks are likely to be losers no matter what the market does

Dow Jones
·
13 Mar

Insider-Favored Growth Stocks To Watch Now

Simply Wall St.
·
13 Mar

They Wanted a Quick Fix for Hair Loss. Instead, These Young Men Got Sick. -- WSJ

Dow Jones
·
13 Mar

Defiance Launches RKLX and HIMZ: 2X Leveraged ETFs for Rocket Lab and Hims & Hers

GlobeNewswire
·
13 Mar

Insiders Favor These 3 High Growth Companies

Simply Wall St.
·
12 Mar

Press Release: Define Ventures Appoints Carolyn Magill as Venture Partner

Dow Jones
·
11 Mar

Hims & Hers Health Discontinues Dermatology Business Apostrophe

MT Newswires Live
·
10 Mar